Concerns Grow Around Gender Surgery for Minors
A recent guest essay in The New York Times suggests that the consensus on gender surgery for younger individuals is beginning to shift. The piece discusses emerging “cracks” in medical consensus as several health organizations in the U.S. revise their policies on treating minors.
The essay references a book by Jesse Singal, which came out on Tuesday, arguing that the previously accepted scientific understanding regarding these procedures is not as universally agreed upon as it once seemed. Singal pointed out that political factors might have influenced past approvals from medical authorities, urging that lack of transparency could undermine public trust in these treatments.
Singal wrote, “I’ve been following this debate from a center-left angle for nearly ten years, and I’ve noticed that even the mildest questioning of these treatments often leads to accusations of bigotry.” This perspective was presented in his article titled “Medical associations’ beliefs are trusted more than science when it comes to youth gender care.”
On February 3, the American Society of Plastic Surgeons (ASPS) released updated guidance recommending that gender-related surgical procedures be postponed until patients reach adulthood. Following suit, the American Medical Association adopted similar guidelines, suggesting these surgeries should wait until individuals are at least 19 years old. The ASPS cited “insufficient evidence” regarding the benefits versus risks of such procedures.
Singal also referenced a significant lawsuit where a New York jury awarded $2 million to a person who transitioned and later sued her medical team over a mastectomy performed when she was just 16. He suggested that such legal actions might compel hospitals and clinics to reconsider their continued provision of these treatments without stronger safeguards.
He observed that the science governing these procedures doesn’t appear “so established after all.” Singal noted, “Such policy statements might reflect intricate and unclear internal politics within organizations rather than purely objective scientific reasoning.” He further questioned, “Should we simply ‘trust the science’? In theory, yes, but only if the science is bolstered by transparency and rigorous analysis.”
The New York Times is among various media outlets exploring the evolving landscape in youth gender medicine, signaling a potential re-evaluation of practices surrounding puberty blockers, hormone therapies, and gender-related surgeries for young individuals.
